Clover Health Investments (CLOV) Gross Profit (2020 - 2026)
Clover Health Investments' (CLOV) quarterly Gross Profit came in at $154.5 million in Q1 2026, up 41.93% YoY from $108.9 million in Q1 2025, and up 271.21% on a QoQ basis from $41.6 million in Q4 2025.
Clover Health Investments (CLOV) Gross Profit (2020 - 2026) Analysis & Trends
Clover Health Investments (CLOV) has 7 years of Gross Profit data on file, last reported at $154.5 million in Q1 2026.
- Quarterly Gross Profit rose 41.93% year-over-year to $154.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $361.2 million (down 1.23% YoY) and the FY2025 annual result came in at $323.3 million, down 4.5% from the prior year.
- Gross Profit rose to $154.5 million in Q1 2026, from $41.6 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $1.8 billion in Q4 2022 to a low of -$590.3 million in Q2 2022.
- A 5-year average of $66.0 million and a median of $70.1 million in 2023 frame the typical range for Gross Profit.
- The widest YoY moves for Gross Profit: up 18790.32% in 2022, down 4040.14% in 2022.
- Tracing CLOV's Gross Profit over 5 years: stood at $1.8 billion in 2022, then plunged by 97.95% to $37.9 million in 2023, then surged by 78.75% to $67.7 million in 2024, then plunged by 38.48% to $41.6 million in 2025, then jumped by 271.21% to $154.5 million in 2026.
- The last three Gross Profit figures came in at $154.5 million (Q1 2026), $41.6 million (Q4 2025), and $73.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|